Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
Aerie Pharmaceuticals (AERI) | RBC Capital Markets/ Stifel | $57.50 | n.a. | |||
Avianca Holdings S.A. (AVH) | J.P. Morgan/ Citigroup | $100.00 | n.a. | |||
CHC Group Ltd. (TBA) | J.P. Morgan/ Barclays/ UBS Investment Bank | $400.00 | n.a. | |||
Cheniere Energy Partners LP Holdings (CQH) | Goldman, Sachs/ Morgan Stanley | $690.00 | n.a. | |||
Essent Group Ltd. (ESNT) | Goldman, Sachs/ J.P. Morgan/ Credit Suisse/ Barclays | $287.50 | n.a. | |||
Global Defense & National Security Systems (GDEF) | Cowen and Company | 6.00 | $10.00 | $10.00 | $60.00 | n.a. |
Valero Energy Partners LP (VLP) | J.P. Morgan/ Barclays | $345.00 | n.a. | |||
Veracyte (VCYT) | Morgan Stanley/ Leerink Swann | $74.75 | n.a. | |||
voxeljet AG (VJET) | Piper Jaffray/ Citigroup | $100.00 | n.a. | |||
n.a. (not available) | ||||||
Postponed | ||||||
Fate Therapeutics (FATE) | Cowen and Company/ BMO Capital Markets | 4.00 | $14.00 | $16.00 | $60.00 | 1-Star |
Withdrawn | ||||||
Babylon Ltd. (BBYL) | Citigroup/ Jefferies | $115.00 | n/c | |||
Bleach Group (tba) | Wellington Shields & Co. | 3.00 | $5.00 | $6.00 | $16.50 | 1-Star |
n/c – no call – shares are traded on the Tel Aviv Stock Exchange | ||||||
New Terms | ||||||
Burlington Holdings (BURL) | J.P. Morgan/ Goldman, Sachs/ Morgan Stanley/ BofA Merrill Lynch/ Wells Fargo Securities | 13.33 | $14.00 | $16.00 | $200.00 | n.a |
Empire State Realty Trust (ESRT) | Goldman, Sachs/ BofA Merrill Lynch | 71.50 | $13.00 | $15.00 | $1,001.00 | n.a |
Enzymotec (ENZY) | BofA Merrill Lynch/ Jefferies | 4.41 | $16.00 | $18.00 | $75.00 | 2-Stars |
FireEye (FEYE) | Morgan Stanley, Goldman, Sachs/ J.P. Morgan/ Barclays/ | 14.00 | $15.00 | $17.00 | $224.00 | 3-Stars |
LDR Holding (LDRH) | Piper Jaffray/ William Blair/ Bryan, Garnier | 5.00 | $14.00 | $16.00 | $75.00 | n.a |
Premier (PINC) | J.P. Morgan/ BofA Merrill Lynch/ Wells Fargo Securities | 28.15 | $23.00 | $26.00 | $689.72 | 1-Star |
RE/MAX Holdings (RMAX) | Morgan Stanley/ BofA Merrill Lynch/ J.P. Morgan | 10.00 | $19.00 | $21.00 | $200.00 | n.a |
Rocket Fuel (FUEL) | Credit Suisse/ Citigroup | 4.00 | $27.00 | $29.00 | $112.00 | 3-Stars |
Violin Memory (VMEM) | J.P. Morgan/ Deutsche Bank Securities/ BofA Merrill Lynch | 18.00 | $8.00 | $10.00 | $162.00 | 2-Stars |
n.a. (not available) | ||||||
IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
Week of Sept.16, 2013 | Manager(s) | Offered | Raised | Price | 9/20/13 | Change |
Rocket Fuel (FUEL) | Credit Suisse/ Citigroup | 4.00 | $116.00 | $29.00 | $56.10 | 93.45% |
Benefitfocus (BNFT) | Goldman, Sachs/ Deutsche Bank Securities/ Jefferies | 4.93 | $130.77 | $26.50 | $50.91 | 92.11% |
FireEye (FEYE) | Morgan Stanley, Goldman, Sachs/ J.P. Morgan/ Barclays/ | 14.00 | $280.00 | $20.00 | $36.00 | 80.00% |
Acceleron Pharma (XLRN) | Citigroup/ Leerink Swann | 5.58 | $83.70 | $15.00 | $20.99 | 39.93% |
Volaris Aviation Holding (VLRS) | Deutsche Bank Securities/ Morgan Stanley / UBS Investment Bank | 28.85 | $346.15 | $12.00 | $13.83 | 15.25% |
Five Prime Therapeutics ( FPRX) | Jefferies/ BMO Capital Markets/ Wells Fargo Securities | 4.80 | $62.40 | $13.00 | $13.74 | 5.69% |
ClubCorp Holdings (MYCC) | Goldman, Sachs/ Jefferies/ Citigroup | 18.00 | $252.00 | $14.00 | $14.50 | 3.57% |
ROI Acquisition Corp. II (ROIQU) | Deutsche Bank Securities | 12.50 | $125.00 | $10.00 | $9.90 | -1.00% |
BIND Therapeutics (BIND) | Credit Suisse/ Cowen and Company | 4.70 | $70.50 | $15.00 | $14.09 | -6.07% |